TOP
Nav Bar
  1. General Info
  2. Source Info
  3. Effects Info
  4. Reference
Phytochemical Details
01. General Information
Name RA-V
PubChem CID 13361282
Molecular Weight 756.8g/mol
Synonyms

deoxybouvardin, RA V, RA-V

Formula C₄₀H₄₈N₆O₉
SMILES CC1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N(C2CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC(C(=O)N1)N(C2=O)C)O)C)C)CC5=CC=C(C=C5)OC)C)C
InChI 1S/C40H48N6O9/c1-22-35(48)42-23(2)38(51)44(4)30(18-25-8-13-28(54-7)14-9-25)37(50)43-24(3)39(52)46(6)32-19-26-10-15-29(16-11-26)55-34-21-27(12-17-33(34)47)20-31(36(49)41-22)45(5)40(32)53/h8-17,21-24,30-32,47H,18-20H2,1-7H3,(H,41,49)(H,42,48)(H,43,50)/t22-,23+,24+,30+,31+,32+/m1/s1
InChIKey VXVGFMUNENQGFW-LZQLRFBTSA-N
ChEMBL ID CHEMBL404613
Structure 2D-img
Download
2D MOL 3D MOL
02. Source Information of Phytochemical
Rubia cordifolia Cold
Chineses Pinyin QianCao
Use Part Root
Habitat Shaanxi, HeBei, ShanDong, HeNan, AnHui
Flavor Bitter
Meridian Tropism Liver
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Gentianales
    -->Family: Rubiaceae
     -->Genus: Rubia
      -->Species: Rubia cordifolia
03. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Drug(s) whose efficacy can be enhanced by this phytochemical
Hide/Show
Combination Pair ID: 510
Pair Name RA-V, Doxorubicin
Partner Name Doxorubicin
Disease Info [ICD-11: 2C77] Cervical cancer Investigative
Biological Phenomena Induction-->Mitochondria-mediated apoptosis
Gene Regulation Up-regulation Expression CYCS hsa54205
In Vitro Model HeLa Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_0030
In Vivo Model The HeLa cells (5×10⁶ cells) were transplanted subcutaneously into the 8-week female BALB/c nude mice by using a stereotactic fixation device with mouse adaptor.
Result This work represents a versatile strategy for precise combination therapy against resistant tumor with spatiotemporal control, and provides a potential tool for Cyt c-related apoptotic studies.
04. Reference
No. Title Href
1 Sequential Delivery of Cyclopeptide RA-V and Doxorubicin for Combination Therapy on Resistant Tumor and In Situ Monitoring of Cytochrome c Release. Theranostics. 2017 Aug 23;7(15):3781-3793. doi: 10.7150/thno.20892. Click
It has been 47505 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP